You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
IGF OT IGF "SBIR PHASE I NEW D HUBIOGEL CULTURE SYSTEM FOR CANCER STEM CELLS EXPANSION and ANALYSIS"
SBC: Vivo Biosciences Inc Topic: NCINot Available
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF ANGIOCRINE BIOSCIENCE INC
SBC: Angiocrine Bioscience Topic: NCINot Available
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF A STAGE BASED MOBILE INTERVENTION FOR SUBSTANCE USE DISORDERS IN PRIMARY CARE N DA POP SEPTEMBER FEBRUARY BASE AWARD
SBC: Pro-Change Behavior Systems, Inc. Topic: NIDANot Available
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF PHENOTYPIC CARDIOTOXICITY SCREENING WITH HUMAN D HEART TISSUES
SBC: Invivosciences, Inc. Topic: NIDANot Available
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF DEVELOPMENT OF NOVEL THERAPEUTIC AGENTS THAT TARGET CANCER STEM CELLS
SBC: NeoStem, Inc. Topic: NCINot Available
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF TITLE SBIR PHASE I VITA CAP TUBE TO PRESERVE CIRCULATING TUMOR CELLS IN BLOOD POP
SBC: VITATEX INC Topic: NCIRecent studies show that proliferative and invasion competent circulating tumor cells CTCs are invaluable in many downstream applications that depend on the ability of the isolated tumor cells to recapitulate tumor growth and metastasis in xenograft mouse models The long term objective of this proposal is to convert the existing Vitatex CTC preparation tube to a closed vacutainer system that is ...
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF RandD NANOEMULSION FORMULATION AND IND ENABLING STUDIES OF A NOVEL CENTER STEM CELL CYTOTOXIC AGENT
SBC: Targagenix, Inc. Topic: NCINot Available
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF Circulating nucleic acid based nanowell label free array technology in cancer
SBC: DETROIT R & D, INC. Topic: NCINot Available
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF Development of a Novel Technology Platform for the Rapid Detection of Cell Free Methylated DNA
SBC: Poointcare Genomics Corporation Topic: NCINot Available
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF VIVO BIOSCIENCES INC
SBC: Vivo Biosciences Inc Topic: NCINot Available
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health